NEWTON, Mass.--(BUSINESS WIRE)--The PGxHealth division of Clinical Data, Inc. (NASDAQ: CLDA), and The George Washington University Medical Faculty Associates Department of Orthopaedic Surgery today announced that they have established a relationship to examine the integration of genomic testing in warfarin treatment.
